[HTML][HTML] Diseases of complement dysregulation—an overview
EKS Wong, D Kavanagh - Seminars in immunopathology, 2018 - Springer
Atypical hemolytic uremic syndrome (aHUS), C3 glomerulopathy (C3G), and paroxysmal
nocturnal hemoglobinuria (PNH) are prototypical disorders of complement dysregulation …
nocturnal hemoglobinuria (PNH) are prototypical disorders of complement dysregulation …
[HTML][HTML] Developments in anti-complement therapy; from disease to clinical trial
The complement system is well known for its role in innate immunity and in maintenance of
tissue homeostasis, providing a first line of defence against infection and playing a key role …
tissue homeostasis, providing a first line of defence against infection and playing a key role …
[HTML][HTML] Complement dysregulation in glomerulonephritis
Glomerulonephritis (GN) refers to a group of renal diseases affecting the glomeruli due to
the damage mediated by immunological mechanisms. A large proportion of the disease …
the damage mediated by immunological mechanisms. A large proportion of the disease …
[HTML][HTML] Diagnostic and prognostic comparison of immune-complex-mediated membranoproliferative glomerulonephritis and C3 glomerulopathy
M Kovala, M Seppälä, A Räisänen-Sokolowski, S Meri… - Cells, 2023 - mdpi.com
Membranoproliferative glomerulonephritis (MPGN) is subdivided into immune-complex-
mediated glomerulonephritis (IC-MPGN) and C3 glomerulopathy (C3G). Classically, MPGN …
mediated glomerulonephritis (IC-MPGN) and C3 glomerulopathy (C3G). Classically, MPGN …
Endothelial cell injury in acute and chronic glomerular lesions in patients with IgA nephropathy
T Kusano, H Takano, D Kang, K Nagahama, M Aoki… - Human pathology, 2016 - Elsevier
Endothelial cell injury may contribute to the progression of various glomerular diseases. In
the present study, we examined glomerular capillary injury in acute and chronic glomerular …
the present study, we examined glomerular capillary injury in acute and chronic glomerular …
[HTML][HTML] Complement and complement targeting therapies in glomerular diseases
S Andrighetto, J Leventhal, G Zaza… - International Journal of …, 2019 - mdpi.com
The complement cascade is part of the innate immune system whose actions protect hosts
from pathogens. Recent research shows complement involvement in a wide spectrum of …
from pathogens. Recent research shows complement involvement in a wide spectrum of …
[HTML][HTML] Renal pathologic findings in TAFRO syndrome: is there a continuum between thrombotic microangiopathy and membranoproliferative glomerulonephritis? A …
A Leurs, V Gnemmi, A Lionet, L Renaud… - Frontiers in …, 2019 - frontiersin.org
Background: TAFRO syndrome is a clinical subtype of idiopathic multicentric Castleman
disease (iMCD) that is characterized by thrombocytopenia, anasarca, fever and/or elevated …
disease (iMCD) that is characterized by thrombocytopenia, anasarca, fever and/or elevated …
Moss-produced, glycosylation-optimized human factor H for therapeutic application in complement disorders
S Michelfelder, J Parsons, LL Bohlender… - Journal of the …, 2017 - journals.lww.com
Genetic defects in complement regulatory proteins can lead to severe renal diseases,
including atypical hemolytic uremic syndrome and C3 glomerulopathies, and age-related …
including atypical hemolytic uremic syndrome and C3 glomerulopathies, and age-related …
[HTML][HTML] Case Report: A case of TAFRO syndrome with severe and prolonged thrombocytopenia: diagnostic pitfalls
H Sato, A Kanno, M Sato, A Endo, H Ito… - Frontiers in …, 2023 - frontiersin.org
Thrombocytopenia, anasarca, myelofibrosis, renal dysfunction, and organomegaly (TAFRO)
syndrome is a rare condition with diverse clinical and pathological characteristics related to …
syndrome is a rare condition with diverse clinical and pathological characteristics related to …
Long‐term outcomes for primary glomerulonephritis: N ew Z ealand G lomerulonephritis S tudy
CL Chembo, MR Marshall, LC Williams… - …, 2015 - Wiley Online Library
Aims Due to the paucity of studies focusing on primary glomerulonephritis, the second
commonest cause of end‐stage‐kidney‐disease in most of the developed world, we sought …
commonest cause of end‐stage‐kidney‐disease in most of the developed world, we sought …